Molecular interaction of bioactive compounds from Senecio biafrae leaf with α-amylase and α-glucosidase receptors
Tóm tắt
Diabetes mellitus is one of the silent killer diseases affecting millions of people globally and some of the key enzymes in managing this disease are α-amylase and α-glucosidase This study was designed to investigate the possible molecular interactions between various bioactive compounds of Senecio biafrae leaf on α-amylase and α-glucosidase (enzymes) receptors an important target protein in Type 2 diabetes mellitus. This study involved the investigation of the of gallic acid, chlorogenic, caffeic acid, rutin, quercetin, and kaempferol (ligands) for Lipinski’s rule of five using Molinspiration, ADMET profiles using admetSAR server and molecular docking of 3D structures of the six bioactive compounds and metformin against α-amylase and α-glucosidase were carried out using AutoDockVina. The results revealed that caffeic acid, quercetin, and kaempferol obey Lipinski’s rule of five. All the ligands demonstrated high gastrointestinal tract absorption except rutin and chlorogenic acid, only one can serve as a P-glycoprotein substrate and three of the ligands used can act as cytochrome P450 inhibitors isoforms. All the ligands had a high binding affinity than metformin (the standard drug used). In can be concluded that some of the bioactive compounds (especially caffeic acid) in Senecio biafrae leaf have antidiabetic activity, which they may serve as a potential antidiabetic drug in the management of diabetes mellitus than metformin.
Tài liệu tham khảo
Adefegha SA, Oboh G. Antioxidant and inhibitory properties of Clerodendrum volubile leaf extracts on key enzymes relevant to non-insulin dependent diabetes mellitus and hypertension. J Taibah Univer Med Sci. 2015;10(4):521–33. https://doi.org/10.1016/j.jtusci.2015.10.008.
Agarwal P, Gupta R. Alpha-amylase inhibition can treat diabetes mellitus. Res Rev J Med Health Sci. 2016;5:1–8.
Ajiboye BO, Edobor G, Ojo AO, Onikanni SA, Olaranwaju OI, Muhammad NO. Effect of aqueous leaf extract of Senecio biafrae on hyperglycaemic and serum lipid profile of alloxan-induced diabetic rats. Inter J Dis Disord. 2014;2(11):059–64.
Ajiboye BO, Ibukun EO, Edobor G, Ojo OA, Onikanni SA. Qualitative and quantitative analysis of phytochemicals in Senecio biafrae leaf. Inter J Pharma Sci and Res. 2013;1(5):428–32.
Ajiboye BO, Ojo OA, Okesola MA, Akinyemi AJ, Talabi JY, Idowu OT, et al. In vitro antioxidant activities and inhibitory effects of phenolic extract of Senecio biafrae (Oliv and Hiern) against key enzymes linked with type II diabetes mellitus and Alzheimer's disease. Food Sci Nut. 2018;6(7):1803–10. https://doi.org/10.1002/fsn3.749.
Ajiboye BO, Oyinloye BE, Agboinghale PE, Onikanni SA, Asogwa E, Kappo AP. Antihyperglycaemia and related gene expressions of aqueous extract of Gongronema latifolium leaf in alloxan-induced diabetic rats. Pharm Biol. 2019;57(1):604–11. https://doi.org/10.1080/13880209.2019.1657907.
Alqahtani AS, Hidayathulla S, Rehman MT, ElGamal AA, Al-Massarani S, Razmovski-Naumovski V, et al. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenaland Katononic Acid Isolated from Nuxia oppositifolia. Biom. 2020;10(1):61. https://doi.org/10.3390/biom10010061.
Coleman RL, Scott CA, Lang Z, Bethel MA, Tuomilehto J, Holman RR. Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovasc Diabe. 2019;18(1):135. https://doi.org/10.1186/s12933-019-0933-y.
Daneman R, Prat A. The Blood–Brain Barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412.
Derosa G, Maffioli P. Mini-special issue paper management of diabetic patients with hypoglycemic agents α-glucosidase inhibitors and their use in clinical practice. Arch Med Sci. 2012;5(5):899–906. https://doi.org/10.5114/aoms.2012.31621.
Elekofehinti OO, Ejelonu OC, Kamdem JP, Akinlosotu OB, Famuti A, Adebowale DD, et al. Discovery of potential visfatin activators using in silico docking and ADME predictions as therapy for type 2 diabetes. Beni-Suef Univ J Bas App Sci. 2018;2018(2):241–9. https://doi.org/10.1016/j.bjbas.2018.02.007.
Etsassala NGR, Badmus JA, Waryo TT, Marnewick JL, Cupido CN, Hussein AA, et al. Alpha-glucosidase and alpha-amylase inhibitory activities of novel Abietane Diterpenes from Salvia africana-lutea. Antioxidants. 2019;8(10):421. https://doi.org/10.3390/antiox8100421.
Gaspar PM, Ewing E. Feasibility and usability of salivary alpha-amylase to measure stress among individuals with dementia. Res Gerontol Nurs. 2019;13(3):120–4. https://doi.org/10.3928/19404921-20191025-02.
Gupta S, Dhanda S, Sandhir R. Anatomy and physiology of blood-brain barrier. Brain Targeted Drug Deliv Syst Els. 2019;2019:7–31. https://doi.org/10.1016/B978-0-12-814001-7.00002-0.
Johnson OO, Adeyemi DK, Adeusi O, Ayoola GA. Evaluation of the phytochemical constituents and antioxidant activity of the stem of Senecio biafrae (Asteraceae). Niger J Pharma Appl Sci Res. 2017;6(2):19–23.
Li Y, Ding Y. Minireview: therapeutic potential of myricetin in diabetes mellitus. Food Sci Human Wellness. 2012;1(1):19–25. https://doi.org/10.1016/j.fshw.2012.08.002.
Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–41. https://doi.org/10.1016/j.ddtec.2004.11.007.
Nisha CM, Kumar A, Vimal A, Bai BM, Pal D, Kumar A. Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor. J Mol Grap Model. 2016;65:100–7. https://doi.org/10.1016/j.jmgm.2016.03.001.
Oboh G. Antioxidant properties of some commonly consumed and underutilized tropical legumes. Europ Food Res Technol. 2006;224(1):61–5. https://doi.org/10.1007/s00217-006-0289-x.
Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Oyinloye BE, Kappo AP. Inhibitory effects of solvent-partitioned fractions of two Nigerian herbs (Spondias mombin Linn. And Mangifera indica L.) on α-amylase and α-glucosidase. Antioxidants. 2018;7(6):73. https://doi.org/10.3390/antiox7060073.
Oyinloye BE, Adekiya TA, Aruleba RT, Ojo OA, Ajiboye BO. Structure-based docking studies of GLUT4 towards exploring selected phytochemicals from Solanum xanthocarpum as a therapeutic target for the treatment of Cancer. Curr Drug DiscoTechnol. 2019;16(4):406–16. https://doi.org/10.2174/1570163815666180801152110.
Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. Complications of diabetes 2016. J Diab Res. 2016;2016:1–3. https://doi.org/10.1155/2016/6989453.
Sivasothy Y, Loo KY, Leong KH, Litaudon M, Awang K. A potent alpha-glucosidase inhibitor from Myristica cinnamomea king. Phyto. 2016;122:265–9. https://doi.org/10.1016/j.phytochem.2015.12.007.
Unuofin JO, Lebelo SL. Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review. Oxid Med Cell Longev. 2020;2020:36. https://doi.org/10.1155/2020/1356893.